Aclarion, Inc. (ACON) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of ...
Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help ...
Aclarion, Inc. announced the termination of its At-The-Market Issuance Sales Agreement with Ascendiant Capital Markets, LLC effective immediately. This decision halts the company’s ability to sell ...
Some results have been hidden because they may be inaccessible to you